Caricamento...
Repurposing Licensed Drugs for Use Against Alzheimer’s Disease
Substantial evidence, composed of drug mechanisms of action, in vivo testing, and epidemiological data, exists to support clinical testing of FDA-approved drugs for repurposing to the treatment of Alzheimer’s disease (AD). Licensed compound investigation can often proceed at a faster and more cost-e...
Salvato in:
| Pubblicato in: | J Alzheimers Dis |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
IOS Press
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8293650/ https://ncbi.nlm.nih.gov/pubmed/33843684 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-210080 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|